ArticleThe Journal of experimental medicine2025

PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancers.

Ying He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.